Complete Filing Data
Oncotelic Therapeutics, Inc. reported Net Income Loss of -$4.52 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oncotelic Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.5M | -$7.9M | $5.1M | -$9.4M | -$9.5M | -$6.6M | -$712.7K | -$13.8M | -$13.7M | -$13.7M | -$12.6M | -$8.3M | -$8.1M | -$9.7M | -$23.8M | -$24.7M |
| Revenue * | $70.0K | $1.7M | $95.0K | $156.0K | ||||||||||||
| Operating Income Loss | -$3.6M | -$6.6M | -$9.7M | -$9.1M | -$7.6M | -$4.3M | -$712.7K | -$13.8M | -$13.8M | -$13.7M | -$12.7M | -$8.3M | -$8.1M | -$11.9M | -$18.5M | -$31.2M |
| Operating Expenses | $3.6M | $6.7M | $9.7M | $9.1M | $9.3M | $4.3M | $712.7K | $13.8M | $13.8M | $13.7M | $12.7M | $8.4M | $8.2M | $11.9M | $18.5M | $31.2M |
| General And Administrative Expense | $376.0K | $573.7K | $4.9M | $5.5M | $5.0M | $2.9M | $63.0K | $3.4M | $5.0M | $4.6M | $5.2M | $4.7M | $4.7M | $5.4M | $5.9M | $8.9M |
| Research And Development Expense | $61.1K | $756.9K | $3.7M | $4.3M | $1.4M | $649.8K | $10.5M | $8.8M | $9.1M | $7.4M | $3.6M | $3.5M | $5.3M | $12.1M | $22.3M | |
| Nonoperating Income Expense | -$1.2M | -$1.6M | $14.4M | -$1.4M | -$2.4M | -$2.3M | ||||||||||
| Other Nonoperating Income Expense | -$1.0K | -$5.0K | -$1.0K | $1.0K | -$3.0K | -$1.0K | -$25.0K | $10.0K | $740.0K | -$63.0K | ||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$255.5K | -$303.0K | -$418.4K | -$1.1M | -$469.2K | -$4.2M | ||||||||||
| Interest Expense | $1.0M | $3.0M | $2.0M | $2.0M | $749.5K | |||||||||||
| Amortization Of Intangible Assets | $12.8K | $51.4K | $326.8K | $51.4K | $34.2K | |||||||||||
| Goodwill Impairment Loss | $6.1M | $4.1M | ||||||||||||||
| Accrued Research And Development | $317.0K | $181.0K | $480.0K | $2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.0M | $277.9K | -$298.7K | -$3.3M | -$209.8K | -$408.7K | $115.3K | -$6.8M | -$525.4K | -$777.9K | $16.0M | -$4.8M | -$1.6M | -$3.2M | -$2.8M | -$2.0M | $582.1K | -$4.7M | -$991.1K | -$1.2M | -$976.1K | -$214.0K | -$153.3K | -$190.8K | -$3.5M | -$3.9M | -$4.0M | -$3.2M | -$3.6M | -$3.3M | -$3.6M | -$3.3M | -$2.8M | -$3.5M | -$3.9M | -$2.6M | -$2.6M | -$1.7M | -$1.9M | -$2.2M | -$2.3M | -$1.9M | -$3.5M | -$2.9M | -$863.0K | -$13.5M | $2.5M | |
| Revenue * | $70.0K | $1.4M | $340.9K | $95.0K | $114.0K | |||||||||||||||||||||||||||||||||||||||||||
| Operating Income Loss | -$491.0K | -$66.0K | -$101.1K | -$3.3M | -$96.6K | -$167.2K | $14.5K | -$6.3M | -$264.1K | -$595.4K | -$256.3K | -$4.3M | -$1.8M | -$3.8M | -$2.0M | -$1.6M | $13.8K | -$2.6M | -$930.7K | -$1.2M | -$976.1K | -$214.0K | -$153.3K | -$795.0K | -$3.5M | -$3.9M | -$4.0M | -$3.3M | -$3.7M | -$3.4M | -$3.6M | -$3.3M | -$2.8M | -$3.5M | -$3.9M | -$2.6M | -$2.6M | -$1.7M | -$1.9M | -$2.2M | -$2.3M | -$1.9M | -$3.6M | -$2.9M | -$3.1M | -$3.6M | -$5.0M | |
| Operating Expenses | $491.0K | $66.0K | $101.1K | $3.3M | $96.6K | $167.2K | $55.5K | $6.3M | $264.1K | $595.4K | $256.3K | $4.3M | $1.8M | $3.8M | $2.0M | $1.6M | $1.4M | $3.0M | $930.7K | $1.2M | $976.1K | $214.0K | $153.3K | $795.0K | $3.5M | $3.9M | $4.0M | $3.3M | $3.7M | $3.4M | $3.6M | $3.3M | $2.8M | $3.5M | $3.9M | $2.6M | $2.7M | $1.7M | $1.9M | $2.2M | $2.3M | $2.0M | $3.6M | $2.9M | $3.1M | $3.6M | $5.0M | |
| General And Administrative Expense | $490.5K | $65.7K | $100.8K | $80.3K | $96.3K | $166.7K | $34.3K | $238.8K | $198.2K | $593.7K | $147.6K | $3.8M | $1.2M | $2.8M | $481.2K | $680.1K | $904.0K | $2.7M | $586.9K | $797.2K | $571.2K | $82.3K | $53.3K | $570.0K | $708.0K | $877.0K | $1.1M | $1.2M | $1.3M | $1.4M | $1.1M | $1.3M | $1.1M | $1.2M | $1.8M | $1.2M | $1.6M | $1.1M | $1.1M | $1.2M | $1.2M | $1.3M | $1.3M | $1.4M | $1.4M | $1.3M | $1.7M | |
| Research And Development Expense | $297.00 | $297.00 | $480.00 | $252.00 | $480.00 | $21.2K | $65.9K | $1.7K | $108.7K | $580.3K | $621.9K | $956.8K | $1.6M | $936.2K | $482.1K | $312.0K | $343.8K | $363.8K | $404.8K | $131.7K | $100.0K | $225.0K | $2.8M | $3.0M | $2.8M | $2.1M | $2.4M | $2.0M | $2.5M | $2.0M | $1.7M | $2.2M | $2.2M | $1.4M | $1.2M | $603.0K | $746.0K | $1.0M | $1.1M | $654.0K | $1.1M | $1.5M | $1.7M | $2.4M | $3.3M | |||
| Nonoperating Income Expense | -$623.4K | $276.4K | -$263.2K | -$90.9K | -$181.6K | -$308.0K | $26.6K | -$528.1K | -$341.9K | -$264.0K | $16.2M | -$746.1K | -$46.6K | $196.2K | -$1.1M | -$370.3K | $568.3K | -$2.0M | -$60.4K | -$28.1K | ||||||||||||||||||||||||||||
| Other Nonoperating Income Expense | -$1.0K | -$3.0K | -$2.0K | -$1.0K | -$1.0K | $2.0K | $1.0K | -$6.0K | -$3.0K | -$10.0K | $4.0K | -$12.0K | -$1.0K | -$2.0K | -$6.0K | -$11.0K | $20.0K | |||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$67.0K | -$67.4K | -$65.5K | -$67.2K | -$68.3K | -$66.5K | -$74.2K | -$93.0K | -$80.6K | -$81.5K | -$41.4K | -$240.5K | -$293.0K | -$336.7K | -$319.6K | $979.5K | ||||||||||||||||||||||||||||||||
| Interest Expense | $234.7K | $185.4K | $257.4K | $394.3K | $606.8K | $1.1M | $297.5K | $445.4K | $434.0K | $520.9K | $331.5K | $137.1K | $1.1M | $60.4K | $28.1K | |||||||||||||||||||||||||||||||||
| Amortization Of Intangible Assets | $0.00 | $12.8K | $12.8K | $12.8K | $12.8K | $12.8K | $81.7K | $12.8K | $12.8K | $12.8K | $12.8K | $8.6K | ||||||||||||||||||||||||||||||||||||
| Goodwill Impairment Loss | $3.2M | $0.00 | $6.1M | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||||||
| Accrued Research And Development | $479.0K | $188.0K | $224.0K | $36.0K | $212.0K | $152.0K | $515.0K | $202.0K | $30.0K | $114.0K | $158.0K | $397.0K | $435.0K | $1.2M | $1.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $12.1M | $19.4M | $8.0M | $11.8M | $16.9M | $2.5M | -$483.6K | $12.5M | $25.4M | $29.0M | $6.0M | $4.5M | $8.8M | -$5.3M | $5.8M | $28.7M | |
| Cash And Cash Equivalents At Carrying Value | $241.5K | $568.8K | $474.0K | $82.0K | $2.5K | $3.5M | $27.3M | $30.0M | $4.6M | $13.9M | $18.3M | ||||||
| Retained Earnings Accumulated Deficit | -$33.5M | -$25.9M | -$31.0M | -$21.6M | -$12.1M | -$5.5M | -$292.3M | -$278.5M | -$264.8M | -$251.2M | -$238.5M | -$225.4M | -$217.4M | -$207.7M | |||
| Liabilities Current | $16.5M | $16.9M | $15.5M | $11.2M | $6.8M | $283.0K | $1.6M | $1.6M | $2.1M | $1.4M | $1.3M | $901.0K | $2.3M | $3.2M | |||
| Liabilities And Stockholders Equity | $30.0M | $36.1M | $23.6M | $23.7M | $23.7M | $2.7M | $1.2M | $14.1M | $27.5M | $30.4M | $7.3M | $5.4M | $11.1M | $5.6M | |||
| Common Stock Value | $4.0M | $3.9M | $3.8M | $906.0K | $840.7K | $68.4K | $265.0K | $265.0K | $265.0K | $207.0K | $56.0K | $17.0K | $13.0K | $55.0K | |||
| Assets Current | $271.7K | $303.2K | $627.3K | $615.6K | $273.0K | $2.5K | $1.1M | $14.1M | $27.4M | $30.4M | $7.2M | $5.2M | $10.6M | $5.0M | |||
| Assets | $30.0M | $36.1M | $23.6M | $23.7M | $23.7M | $2.7M | $1.2M | $14.1M | $27.5M | $30.4M | $7.3M | $5.4M | $11.1M | $5.6M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $261.5K | $588.8K | $494.0K | $82.0K | $2.5K | $3.5K | |||||||||||
| Goodwill | $12.1M | $21.1M | $21.1M | $21.1M | |||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$486.0K | -$2.4M | -$23.8M | -$2.7M | $23.0M | $2.1M | -$5.0M | $5.4M | -$9.3M | -$4.3M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$84.3K | -$71.0K | -$327.3K | $94.8K | $412.1K | $79.5K | -$980.00 | ||||||||||
| Finite Lived Intangible Assets Accumulated Amortization | $201.2K | $188.3K | $137.0K | $85.6K | $34.2K | $1.5M | $1.4M | $1.3M | $1.2M | $1.1M | |||||||
| Accounts Payable Current | $788.0K | $310.0K | $287.0K | $335.0K | $476.0K | $416.0K | $261.0K | $458.0K | |||||||||
| Derivative Liabilities Current | $423.2K | $198.1K | $340.3K | $777.0K | $540.5K | ||||||||||||
| Property Plant And Equipment Net | $2.0K | $11.0K | $30.0K | $37.0K | $36.0K | $13.0K | $34.0K | $87.0K | |||||||||
| Other Accrued Liabilities Current | $279.0K | $398.0K | $262.0K | $223.0K | $342.0K | $304.0K | $865.0K | $628.0K | |||||||||
| Additional Paid In Capital Common Stock | $291.5M | $290.7M | $289.9M | $280.0M | $244.5M | $230.0M | $226.1M | $202.4M | |||||||||
| Prepaid Expense And Other Assets | $62.4K | $22.0K | $18.8K | $101.9K | $41.3K | ||||||||||||
| Finite Lived Intangible Assets Net | $821.8K | $873.2K | $924.6K | $976.0K | $0.00 | $93.0K | $191.0K | $289.0K | $386.0K | ||||||||
| Accounts Receivable Net Current | $19.0K | $19.7K | $19.7K | $19.7K | $149.7K | ||||||||||||
| Accounts Payable And Accrued Liabilities Current | $2.4M | $2.5M | $3.1M | $2.7M | $2.1M | ||||||||||||
| Property Plant And Equipment Other | $1.1M | $1.1M | $1.1M | $1.1M | $1.4M | ||||||||||||
| Business Combination Contingent Consideration Liability Current | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | ||||||||||||
| Restricted Cash | $20.0K | $20.0K | $20.0K | $20.0K | |||||||||||||
| Minority Interest | -$518.6K | -$215.6K | $202.8K | $709.0K | |||||||||||||
| Gains Losses On Extinguishment Of Debt | -$88.3K | -$373.1K | -$257.8K | -$27.5K | -$343.7K | ||||||||||||
| Other Assets Noncurrent | $33.0K | $33.0K | $33.0K | $33.0K | $86.0K | $86.0K | |||||||||||
| Cash | $241.5K | $568.8K | $474.0K | $82.0K | $2.5K | $3.5M | $27.3M | $30.0M | $4.6M | $13.9M | $18.3M | ||||||
| Accrued Employee Benefits Current | $73.0K | $842.0K | $636.0K | $841.0K | $116.0K | ||||||||||||
| Accounts Payable Related Parties Current | $332.4K | $403.4K | $391.6K | $601.7K | $283.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $9.1M | $8.3M | $8.0M | $8.3M | $8.9M | $12.2M | $11.8M | $11.6M | $12.5M | $12.3M | $18.7M | $24.2M | $24.4M | $6.4M | $8.0M | $8.9M | $10.0M | $14.9M | $15.8M | $15.1M | $4.8M | $5.6M | $2.5M | $2.5M | -$375.6K | -$332.0K | -$313.2K | $1.8M | $5.1M | $8.8M | $15.8M | $18.8M | $22.2M | $29.0M | $32.5M | $35.5M | $31.6M | $34.9M | $23.9M | $7.7M | $7.4M | $4.3M | $5.6M | $6.1M | $7.5M | $10.4M | $7.2M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $409.0K | $88.0K | $79.2K | $86.1K | $149.0K | $72.2K | $189.0K | $170.4K | $253.9K | $399.8K | $97.9K | $78.1K | $461.3K | $830.7K | $1.4M | $660.9K | $183.4K | $16.2K | $84.3K | $200.0K | $1.1M | $2.0M | $233.0K | $1.1M | $1.9M | $5.0M | $6.0M | $5.2M | $7.9M | $13.0M | $30.3M | $33.1M | $35.7M | $7.7M | $4.6M | $4.9M | $6.3M | $6.9M | $8.1M | $10.0M | $12.6M | $8.5M | $2.6M | $6.5M | $7.2M | ||||||||||
| Retained Earnings Accumulated Deficit | -$39.1M | -$38.1M | -$38.3M | -$38.0M | -$37.4M | -$34.1M | -$33.9M | -$32.8M | -$32.9M | -$26.1M | -$20.6M | -$19.9M | -$35.9M | -$29.2M | -$27.7M | -$24.4M | -$18.2M | -$16.2M | -$16.8M | -$8.6M | -$7.7M | -$295.6M | -$294.4M | -$293.7M | -$293.1M | -$289.8M | -$286.3M | -$282.4M | -$275.0M | -$271.8M | -$268.1M | -$260.8M | -$257.3M | -$253.9M | -$248.5M | -$245.1M | -$241.1M | -$236.4M | -$229.0M | -$227.3M | -$223.8M | -$221.5M | -$219.2M | -$215.0M | -$211.5M | ||||||||||
| Liabilities Current | $20.1M | $19.3M | $19.5M | $19.2M | $16.4M | $16.2M | $16.5M | $17.1M | $18.1M | $17.6M | $16.2M | $16.1M | $16.8M | $14.8M | $14.1M | $13.0M | $8.8M | $8.2M | $8.5M | $2.7M | $2.0M | $1.2M | $1.1M | $1.6M | $1.5M | $1.2M | $1.4M | $1.4M | $1.5M | $1.6M | $2.0M | $1.7M | $1.2M | $1.0M | $1.7M | $1.9M | $1.4M | $1.5M | $891.0K | $833.0K | $1.3M | $1.6M | $1.5M | $3.0M | $2.2M | ||||||||||
| Liabilities And Stockholders Equity | $28.2M | $26.7M | $26.7M | $26.7M | $26.8M | $29.9M | $30.0M | $30.1M | $30.0M | $36.0M | $40.2M | $40.4M | $23.1M | $23.2M | $23.7M | $24.0M | $24.6M | $24.0M | $23.6M | $7.5M | $7.7M | $391.0K | $1.1M | $2.1M | $437.0K | $3.0M | $6.5M | $10.2M | $17.3M | $20.4M | $24.2M | $30.7M | $33.6M | $36.6M | $33.3M | $36.8M | $25.2M | $9.2M | $8.3M | $5.2M | $6.9M | $7.7M | $9.0M | $13.4M | $9.5M | ||||||||||
| Common Stock Value | $4.4M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.0M | $4.0M | $4.0M | $3.9M | $3.9M | $3.9M | $3.8M | $3.7M | $3.7M | $3.7M | $896.0K | $886.0K | $880.3K | $834.7K | $834.7K | $414.0K | $414.0K | $414.0K | $265.0K | $265.0K | $265.0K | $265.0K | $265.0K | $265.0K | $265.0K | $265.0K | $265.0K | $265.0K | $207.0K | $207.0K | $153.0K | $30.0K | $23.0K | $21.0K | $198.0K | $175.0K | $162.0K | $148.0K | $117.0K | ||||||||||
| Assets Current | $1.6M | $137.6K | $125.0K | $134.2K | $239.0K | $192.0K | $231.2K | $365.5K | $281.6K | $232.7K | $312.0K | $463.2K | $158.3K | $188.8K | $694.4K | $955.2K | $1.5M | $783.0K | $274.2K | $71.0K | $189.2K | $340.0K | $1.1M | $2.1M | $404.0K | $2.9M | $6.5M | $10.1M | $17.2M | $20.4M | $24.2M | $30.7M | $33.6M | $36.5M | $33.2M | $36.7M | $25.1M | $9.1M | $8.2M | $5.0M | $6.6M | $7.5M | $8.6M | $12.9M | $9.0M | ||||||||||
| Assets | $28.2M | $26.7M | $26.7M | $26.7M | $26.8M | $29.9M | $30.0M | $30.1M | $30.0M | $36.0M | $40.2M | $40.4M | $23.1M | $23.2M | $23.7M | $24.0M | $24.6M | $24.0M | $23.6M | $7.5M | $7.7M | $391.0K | $1.1M | $2.1M | $437.0K | $3.0M | $6.5M | $10.2M | $17.3M | $20.4M | $24.2M | $30.7M | $33.6M | $36.6M | $33.3M | $36.8M | $25.2M | $9.2M | $8.3M | $5.2M | $6.9M | $7.7M | $9.0M | $13.4M | $9.5M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $429.0K | $108.0K | $99.2K | $106.1K | $169.0K | $92.2K | $209.0K | $190.4K | $288.0K | $201.9K | $210.4K | $273.9K | $419.8K | $117.9K | $98.1K | $481.3K | $830.7K | $1.4M | $660.9K | $183.4K | $16.2K | $84.3K | $483.00 | $2.5K | $2.6K | ||||||||||||||||||||||||||||||
| Goodwill | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $12.1M | $16.2M | $16.2M | $21.1M | $21.1M | $21.1M | $21.1M | $21.1M | $21.1M | $21.1M | $4.8M | $4.8M | |||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$429.0K | -$882.0K | $2.5M | -$17.0M | $5.7M | $17.7M | -$384.0K | -$1.8M | -$2.0M | ||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.0K | $18.6K | -$51.0K | -$470.9K | $356.7K | $101.5K | -$3.0K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Finite Lived Intangible Assets Accumulated Amortization | $201.2K | $201.2K | $201.2K | $175.5K | $162.7K | $98.4K | $124.1K | $111.3K | $98.4K | $72.8K | $59.9K | $1.5M | $1.5M | $1.4M | $1.4M | $1.4M | $1.3M | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | |||||||||||||||||||||||||||||||||
| Accounts Payable Current | $343.0K | $332.4K | $901.0K | $915.0K | $772.0K | $1.2M | $1.2M | $312.0K | $401.0K | $312.0K | $532.0K | $501.0K | $475.0K | $317.0K | $178.0K | $189.0K | $365.0K | $849.0K | $432.0K | $733.0K | $430.0K | $445.0K | $509.0K | $535.0K | $138.0K | $473.0K | $440.0K | ||||||||||||||||||||||||||||
| Derivative Liabilities Current | $670.8K | $278.8K | $763.0K | $703.6K | $282.4K | $397.1K | $420.7K | $218.9K | $525.7K | $218.0K | $302.6K | $408.2K | $531.1K | $393.2K | $538.6K | $1.2M | $776.5K | $991.5K | $1.8M | ||||||||||||||||||||||||||||||||||||
| Property Plant And Equipment Net | $19.5K | $28.8K | $38.1K | $47.6K | $4.0K | $6.0K | $8.0K | $14.0K | $19.0K | $25.0K | $36.0K | $42.0K | $32.0K | $30.0K | $28.0K | $32.0K | $5.0K | $8.0K | $10.0K | $23.0K | $28.0K | $27.0K | $43.0K | $55.0K | |||||||||||||||||||||||||||||||
| Other Accrued Liabilities Current | $43.0K | $69.0K | $200.0K | $172.0K | $247.0K | $330.0K | $421.0K | $531.0K | $410.0K | $406.0K | $333.0K | $169.0K | $255.0K | $202.0K | $286.0K | $183.0K | $448.0K | $580.0K | $431.0K | $274.0K | $473.0K | $451.0K | $437.0K | $212.0K | $581.0K | ||||||||||||||||||||||||||||||
| Additional Paid In Capital Common Stock | $294.4M | $294.2M | $294.0M | $293.8M | $291.7M | $291.3M | $291.1M | $290.9M | $290.5M | $290.3M | $290.1M | $289.6M | $289.5M | $289.2M | $279.9M | $279.8M | $264.8M | $244.1M | $236.4M | $231.7M | $229.2M | $227.7M | $226.6M | $225.3M | $218.6M | ||||||||||||||||||||||||||||||
| Prepaid Expense And Other Assets | $1.2M | $10.6K | $6.8K | $9.1K | $51.0K | $80.8K | $3.2K | $58.5K | $60.7K | $2.5K | $18.4K | $23.7K | $20.7K | $20.9K | $56.9K | $84.7K | $88.0K | $102.4K | $71.0K | ||||||||||||||||||||||||||||||||||||
| Finite Lived Intangible Assets Net | $809.0K | $834.7K | $847.5K | $860.4K | $886.0K | $898.9K | $911.7K | $937.4K | $950.3K | $23.0K | $47.0K | $70.0K | $118.0K | $142.0K | $167.0K | $215.0K | $240.0K | $264.0K | $313.0K | $337.0K | |||||||||||||||||||||||||||||||||||
| Accounts Receivable Net Current | $4.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.7K | $19.7K | $19.7K | $19.7K | $69.8K | $156.3K | $19.7K | $19.7K | $19.7K | $19.7K | ||||||||||||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $2.6M | $2.5M | $2.5M | $2.4M | $2.5M | $2.5M | $2.4M | $2.9M | $2.9M | $3.5M | $4.4M | $4.1M | $3.6M | $2.7M | $2.5M | $2.2M | $1.6M | $1.4M | |||||||||||||||||||||||||||||||||||||
| Property Plant And Equipment Other | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |||||||||||||||||||||||||||||||||||||||
| Business Combination Contingent Consideration Liability Current | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | |||||||||||||||||||||||||||||||||||||||
| Restricted Cash | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | ||||||||||||||||||||||||||||||||||||||
| Minority Interest | -$974.1K | -$907.1K | -$839.7K | -$774.1K | -$720.6K | -$653.4K | -$585.1K | -$463.5K | -$389.3K | -$296.2K | -$160.7K | -$79.2K | -$37.8K | $379.7K | $672.7K | $1.0M | $979.5K | ||||||||||||||||||||||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | -$88.3K | -$94.8K | -$257.8K | -$27.5K | -$88.8K | -$41.5K | -$124.6K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets Noncurrent | $1.8K | $1.8K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $86.0K | $86.0K | $86.0K | |||||||||||||||||||||||||||||||||||||
| Cash | $409.0K | $88.0K | $79.2K | $86.1K | $149.0K | $72.2K | $189.0K | $170.4K | $253.9K | $399.8K | $97.9K | $78.1K | $461.3K | $830.7K | $1.4M | $660.9K | $183.4K | $16.2K | $84.3K | $200.0K | $1.1M | $2.0M | $233.0K | $1.1M | $1.9M | $5.0M | $6.0M | $5.2M | $7.9M | $13.0M | $30.3M | $33.1M | $35.7M | $7.7M | $4.6M | $4.9M | $6.3M | $6.9M | $8.1M | $10.0M | $12.6M | $8.5M | $2.6M | $6.5M | $7.2M | ||||||||||
| Accrued Employee Benefits Current | $49.0K | $24.0K | $15.0K | $40.0K | $23.0K | $261.0K | $483.0K | $488.0K | $497.0K | $474.0K | $459.0K | $733.0K | $545.0K | $414.0K | $811.0K | $764.0K | |||||||||||||||||||||||||||||||||||||||
| Accounts Payable Related Parties Current | $349.5K | $339.5K | $358.1K | $425.7K | $323.0K | $365.3K | $385.0K | $644.3K | $763.0K | $610.3K | $400.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $902.1K | $763.3K | $2.1M | $340.7K | $80.0K | $835.0K | $804.0K | $806.0K | $414.0K | $679.0K | $511.0K | $851.0K | $952.0K | $530.0K | ||
| Financing Cash Flow * | $656.0K | $1.3M | $1.1M | $4.5M | $3.2M | $2.2M | $240.0K | $9.2M | $35.2M | $9.1M | $3.3M | $17.2M | $11.1M | $21.4M | ||
| Investing Cash Flow * | $189.3K | $8.5M | -$8.5M | -$13.0K | -$17.0K | -$35.0K | -$8.0K | $3.0K | $2.9M | |||||||
| Operating Cash Flow * | -$740.3K | -$1.3M | -$1.5M | -$4.4M | -$2.8M | -$2.3M | -$241.0K | -$10.9M | -$15.2M | -$11.9M | -$12.2M | -$7.0M | -$8.3M | -$11.8M | -$20.4M | -$28.7M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $293.2K | -$72.8K | $874.0K | $210.4K | $680.8K | $616.0K | $37.8K | $35.0K | -$489.0K | $684.0K | $168.0K | $350.0K | -$1.4M | -$956.0K | -$4.3M | $1.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$53.2K | $40.4K | $3.2K | -$83.1K | -$69.4K | $78.6K | -$26.1K | -$2.0M | $1.9M | -$217.0K | $195.0K | -$117.0K | -$464.0K | $9.0K | -$457.0K | $210.0K |
| Proceeds From Issuance Of Common Stock | $158.8K | $420.3K | $83.0K | $240.0K | $9.2M | $25.7M | $1.9M | $3.3M | $17.1M | $11.0M | $9.0M | |||||
| Increase Decrease In Accounts Payable Related Parties | $2.0K | $26.8K | -$71.0K | $11.8K | -$210.1K | $556.7K | ||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $112.0K | $101.8K | $64.4K | $268.0K | $357.0K | $609.0K | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $297.4K | $2.1M | $268.3K | $184.0K | $240.0K | $192.0K | $88.0K | $84.0K | $173.0K | $136.0K | $64.0K | $157.0K | $176.0K | ||||||||||||||||||
| Financing Cash Flow * | $160.0K | $250.0K | $200.0K | $491.8K | $1.6M | $70.0K | $115.0K | $9.2M | $20.4M | $1.5M | $471.0K | $1.6M | |||||||||||||||||||
| Investing Cash Flow * | $6.2M | -$12.6M | -$12.0K | ||||||||||||||||||||||||||||
| Operating Cash Flow * | -$167.0K | -$231.4K | -$251.0K | -$962.7K | -$1.3M | $31.5K | -$118.0K | -$882.0K | -$3.7M | -$4.4M | -$3.5M | -$2.6M | -$1.9M | -$2.3M | -$3.6M | ||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $96.3K | $89.1K | $134.6K | $364.5K | $879.8K | $179.9K | -$112.4K | -$125.0K | -$221.0K | -$79.0K | -$390.0K | $144.0K | -$68.0K | -$783.0K | -$425.0K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.3K | -$18.7K | -$19.4K | $1.9K | -$17.2K | -$100.3K | -$33.1K | $149.0K | -$233.0K | $1.2M | $434.0K | $249.0K | $146.0K | -$210.0K | $285.0K | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | $51.8K | $83.0K | $9.2M | $10.9M | $1.5M | $471.0K | $1.6M | ||||||||||||||||||||||||
| Increase Decrease In Accounts Payable Related Parties | $513.00 | $12.1K | $14.7K | -$45.3K | -$26.3K | $161.3K | |||||||||||||||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $109.4K | $106.9K | $73.8K | $83.2K | $83.2K | $73.8K | $233.0K | $252.0K | $247.0K | $242.0K | $238.0K | $276.0K | $272.0K | $360.0K | $357.0K | $361.0K | $621.0K | $616.0K | $616.0K | $793.0K | $781.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | $0.01 | -$0.03 | -$0.11 | -$0.11 | -$0.12 | -$0.52 | -$0.51 | -$0.54 | -$0.75 | -$4.67 | -$5.48 | -$10.37 | -$71.60 | -$13.15 | |
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 150.0M | 150.0M | 150.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 100.0M | 300.0M | 300.0M | ||
| Common Stock Shares Outstanding | 399.2M | 391.8M | 375.3M | 90.6M | 84.1M | 6.8M | 26.5M | 26.5M | 26.5M | 20.7M | 5.6M | 1.7M | 1.3M | 5.5M | ||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Common Stock Shares Issued | 399.2M | 391.8M | 375.3M | 90.6M | 84.1M | 6.8M | 26.5M | 26.5M | 26.5M | 20.7M | 5.6M | 1.7M | 1.3M | 5.5M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | ||||
| Preferred Stock Shares Outstanding | 278.2K | 278.2K | 278.2K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 278.2K | 278.2K | 278.2K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 88.1M | 60.0M | 6.1M | 26.5M | 26.5M | 25.2M | 17.0M | 2.8M | 1.5M | 931.0K | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 404.4M | 384.1M | 384.1M | 303.1M | 88.1M | |||||||||||
| Earnings Per Share Basic | $-0.01 | $-0.02 | $0.01 | $-0.03 | $-0.11 | |||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 396.2M | 457.3M | 303.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | -$0.01 | -$0.03 | -$0.02 | $0.01 | -$0.05 | -$0.01 | -$0.02 | -$0.14 | -$0.04 | -$0.03 | -$0.03 | -$0.13 | -$0.15 | -$0.15 | -$0.12 | -$0.14 | -$0.13 | -$0.14 | -$0.13 | -$0.13 | -$0.17 | -$0.23 | -$0.29 | -$1.88 | -$1.86 | -$0.97 | -$1.56 | -$1.65 | -$1.44 | -$0.25 | -$0.32 | -$0.13 | -$3.47 | $0.73 | ||||||||
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 150.0M | 750.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 100.0M | 100.0M | 100.0M | 300.0M | 300.0M | 300.0M | ||||||||
| Common Stock Shares Outstanding | 439.4M | 408.3M | 408.3M | 407.3M | 407.3M | 407.3M | 399.7M | 398.2M | 397.5M | 392.9M | 390.2M | 386.0M | 378.6M | 372.6M | 370.1M | 369.4M | 89.6M | 88.6M | 88.0M | 83.5M | 83.5M | 41.4M | 41.4M | 41.4M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 20.7M | 20.7M | 15.3M | 3.0M | 2.3M | 2.1M | 19.8M | 17.5M | 16.2M | 14.8M | 11.7M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||||
| Common Stock Shares Issued | 439.4M | 408.3M | 408.3M | 407.3M | 407.3M | 407.3M | 399.7M | 398.2M | 397.5M | 392.9M | 390.2M | 386.0M | 378.6M | 372.6M | 370.1M | 369.4M | 89.6M | 88.6M | 88.0M | 83.5M | 83.5M | 41.4M | 41.4M | 41.4M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 20.7M | 20.7M | 15.3M | 3.0M | 2.3M | 2.1M | 19.8M | 17.5M | 16.2M | 14.8M | 11.7M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||||||||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | |||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 278.2K | 278.2K | 278.2K | 193.7K | 193.7K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.0K | 5.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 278.2K | 278.2K | 278.2K | 193.7K | 193.7K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.0K | 5.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 94.2M | 89.0M | 84.9M | 74.5M | 65.4M | 6.9M | 6.1M | 6.1M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 26.5M | 21.1M | 20.7M | 17.3M | 9.1M | 2.6M | 2.2M | 1.9M | 1.5M | |||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 426.4M | 408.3M | 407.4M | 407.3M | 401.6M | 399.4M | 397.8M | 394.4M | 392.4M | 386.8M | 379.2M | 377.4M | 370.4M | 369.5M | 94.2M | 89.0M | 88.2M | 65.4M | ||||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $-0.02 | $0.00 | $0.00 | $0.04 | $-0.01 | $0.00 | $-0.01 | $-0.03 | $-0.02 | $0.01 | $-0.02 | ||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 452.8M | 407.4M | 407.3M | 401.6M | 399.4M | 397.8M | 392.4M | 386.8M | 418.8M | 370.4M | 369.5M | 94.7M | 65.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $123.00 | $16.0K | $35.0K | $106.0K | $27.0K | $6.0K | $4.0K | $12.0K | $7.0K | $17.0K | $110.0K | |||||
| Depreciation | $10.1K | $37.4K | $9.2K | $2.0K | $9.0K | $19.0K | $20.0K | $16.0K | $12.0K | $29.0K | $53.0K | $96.0K | $123.0K | |||
| Derivative Gain Loss On Derivative Net | -$280.4K | -$225.1K | $142.2K | $292.1K | -$45.1K | $191.6K | ||||||||||
| Additional Paid In Capital | $41.7M | $41.4M | $35.2M | $32.5M | $28.2M | $7.9M | ||||||||||
| Amortization Of Financing Costs And Discounts | $122.1K | $301.9K | $2.0M | $1.5M | $1.3M | $746.0K | ||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $645.4K | $504.9K | $624.8K | $210.3K | $906.4K | |||||||||||
| Interest Paid Net | $365.9K | $390.6K | $398.0K | $299.4K | $52.1K | |||||||||||
| Prepaid Expense Current | $1.9M | $38.0K | $93.0K | $135.0K | $582.0K | $256.0K | ||||||||||
| Stock Issued During Period Value New Issues | $158.8K | $420.3K | $83.0K | $240.0K | $9.1M | $2.0M | ||||||||||
| Adjustment For Amortization | $93.0K | $98.0K | $98.0K | $97.0K | $98.0K | $97.0K | ||||||||||
| Reimbursement For Expenses Related Party | -$22.9K | -$72.2K | -$533.5K | |||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $328.6K | $2.9M | $601.0K | $427.4K | $9.5M | |||||||||||
| Investment Owned At Fair Value | $22.7M | $22.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $10.00 | $123.00 | $1.0K | $5.0K | $7.0K | $1.0K | $7.0K | $12.0K | $14.0K | $26.0K | $29.0K | $28.0K | $7.0K | $5.0K | $3.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $3.0K | $5.0K | $1.0K | $1.0K | $1.0K | $3.0K | $4.0K | ||||||||||||||||||||
| Depreciation | $2.5K | $9.3K | $2.0K | $3.0K | $5.0K | $5.0K | $4.0K | $3.0K | $7.0K | $17.0K | |||||||||||||||||||||||||||||||||||||||
| Derivative Gain Loss On Derivative Net | -$392.1K | $484.2K | -$59.4K | $114.7K | $23.6K | $2.5K | $306.8K | -$307.7K | -$19.9K | $105.7K | $122.9K | -$190.8K | $145.4K | $630.2K | -$536.3K | $50.0K | $746.8K | -$736.3K | |||||||||||||||||||||||||||||||
| Additional Paid In Capital | $43.8M | $42.3M | $42.3M | $42.2M | $42.2M | $42.2M | $41.8M | $41.3M | $41.2M | $41.0M | $40.9M | $40.4M | $38.4M | $33.5M | $32.9M | $30.7M | $32.2M | $31.1M | $31.0M | $12.6M | $12.4M | ||||||||||||||||||||||||||||
| Amortization Of Financing Costs And Discounts | $38.9K | $38.0K | $166.4K | $176.7K | $421.2K | $1.1M | |||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $316.1K | $70.2K | $532.4K | $113.0K | $35.3K | $326.2K | $71.7K | $241.8K | $331.3K | $210.3K | $238.1K | ||||||||||||||||||||||||||||||||||||||
| Interest Paid Net | $94.8K | $94.8K | $99.8K | $100.9K | $65.8K | ||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Expense Current | $54.8K | $105.0K | $772.0K | $1.2M | $1.5M | $755.0K | $318.0K | $279.0K | $450.0K | $368.0K | $172.0K | $370.0K | $337.0K | $220.0K | $460.0K | $397.0K | $195.0K | $396.0K | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $60.2K | $46.8K | $51.8K | $109.7K | $99.1K | $83.0K | $200.0K | ||||||||||||||||||||||||||||||||||||||||||
| Adjustment For Amortization | $23.0K | $24.0K | $25.0K | $24.0K | |||||||||||||||||||||||||||||||||||||||||||||
| Reimbursement For Expenses Related Party | -$10.4K | -$12.5K | -$72.2K | -$237.2K | -$247.5K | ||||||||||||||||||||||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $368.4K | $2.9M | $2.0M | $166.6K | $365.4K | ||||||||||||||||||||||||||||||||||||||||||||
| Investment Owned At Fair Value | $22.7M | $22.7M | $22.7M | $22.7M | $22.7M | $22.7M | $22.7M | $22.6M | $22.6M | $22.6M | $22.6M |
Most recent annual filing with the SEC: April 15, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.